NCT00125554View on ClinicalTrials.gov

Metyrapone as Additive Treatment in Major Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 31, 1998

Study Completion Date

July 31, 2001

Conditions
Major Depressive Disorder
Interventions
DRUG

Metyrapone

Trial Locations (1)

20246

Dept. of Psychiatry and Psychotherapy, UKE, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT00125554 - Metyrapone as Additive Treatment in Major Depression | Biotech Hunter | Biotech Hunter